Indian benchmark indices extended their winning streak on Thursday, led by gains in IT and pharma stocks. The Nifty ended at 25,423.60, up 93.35 points or 0.37%, while the BSE Sensex closed at 83,013.96, rising 320.25 points or 0.39%. Here are seven stocks …

… . (BBL), a subsidiary of Biocon Ltd., has achieved a key …

… to meet public shareholding norms. Biocon: Biocon Biologics has received US FDA …

… on Thursday after its subsidiary, Biocon Biologics, received U.S. … market adoption. On Wednesday, Biocon Biologics said the FDA cleared … . In the June quarter, Biocon reported a 95% year-on … Eris Lifesciences. On Wednesday, Biocon shares closed 1.6% lower …

… organization on August 17, 2025. Biocon: The pharma company's … subsidiary, Biocon Biologics, said that the USFDA …

… , Apollo Tyres, Hyundai India, LTIMindtree, Biocon among others will be in … Rs 200 crore. Biocon Biocon Biologics, a subsidiary of Biocon, announced that the …

… interest in ONGC. Biocon  Biocon Biologics, a subsidiary of Biocon, on Wednesday said …

… , a subsidiary of Biocon Ltd, on Wednesday said it … and Xgeva $1.6 billion. Biocon Biologics CEO & MD Shreehas …

Bengaluru: Biocon Biologics Ltd., a fully integrated … biosimilars company and subsidiary of Biocon Ltd., has announced that the … Tambe, CEO & Managing Director, Biocon Biologics, said, “The FDA’s …